Impact of Reboxetine plus Oxybutynin treatment for Obstructed Sleep Apnea on the Cardiovascular Autonomic Activity
E. Perger (Milano, Italy), P. Castiglioni (Milano, Italy), D. Rosa (Milano, Italy), S. Vicini (Milano, Italy), P. Meriggi (Milano, Italy), A. Faini (Milano, Italy), L. Pini (Brescia, Italy), L. Taranto Montemurro (Boston, United States of America), C. Lombardi (Milano, Italy), G. Parati (Milano, Italy)
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Perger (Milano, Italy), P. Castiglioni (Milano, Italy), D. Rosa (Milano, Italy), S. Vicini (Milano, Italy), P. Meriggi (Milano, Italy), A. Faini (Milano, Italy), L. Pini (Brescia, Italy), L. Taranto Montemurro (Boston, United States of America), C. Lombardi (Milano, Italy), G. Parati (Milano, Italy). Impact of Reboxetine plus Oxybutynin treatment for Obstructed Sleep Apnea on the Cardiovascular Autonomic Activity. 750
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: